Back
Bio-Techne Corp (TECH)
Life Sciences Tools & ServicesTECH · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$71.29
+0.19%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$0.46
ROE
5.3%
Gross margin
66.4%
Debt/Equity
0.14x
Revenue growth
-1.5%
Bio-Techne Corp — company intelligence
Earnings surprises
Q3 2026$0.53 vs $0.55 est-3.3%
Q2 2026$0.46 vs $0.44 est+4.0%
Q1 2026$0.42 vs $0.43 est-2.0%
Q4 2025$0.53 vs $0.51 est+4.1%
Analyst consensus · 22 analysts
16 Buy5 Hold1 Sell
Updated Jul 4, 2026
Insider activity · 90 days
0 buys8 sellsnet -178,036 shares
Crouse Steven C.other 600 · Jun 2, 2026
Crouse Steven C.Sell 216 · Jun 2, 2026
Herr Amy E.other 6,636 · May 8, 2026
Recent SEC filings
8-K — Material event reportJun 26, 2026
8-K — Material event reportJun 25, 2026
4 — Insider transaction reportJun 4, 2026
Latest news
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session. — ChartMill · 1w ago
TD Cowen Downgrades Bio-Techne to Hold, Raises Price Target to $73 — Benzinga · 1w ago
Benchmark Downgrades Bio-Techne to Hold — Benzinga · 1w ago
Which S&P500 stocks have an unusual volume on Monday? — ChartMill · 1w ago
Citigroup Downgrades Bio-Techne to Neutral, Raises Price Target to $73 — Benzinga · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Bio-Techne Corp
Weekly undervalued picks (like TECH)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.